Macquarie Group
LONA

Macquarie Group’s LeonaBio Inc LONA Stock Holding History

Macquarie Group’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-52
Closed -$1 – 1914
2024
Q1 		$1 Buy
+52
New +$1.65K ﹤0.01% 1863
2020
Q4 		– Sell
-500
Closed -$92K – 2354
2020
Q3 		$92K Buy
+500
New +$83.5K ﹤0.01% 1805

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Macquarie Group's LONA Position: Q2 2024 in Review

Macquarie Group sold out of LeonaBio Inc (LONA) in Q2 2024, closing a stake of 52 shares — an estimated $1 sold.

Macquarie Group first reported a position in LONA in Q3 2020 and held it in 2 quarters. The position peaked at $92K in Q3 2020. 65 funds tracked by Wall St. Rank hold LONA as of Q2 2024.

  • Macquarie Group reported no remaining LeonaBio Inc position as of Q2 2024 after selling out during the quarter.
  • Macquarie Group sold 52 LeonaBio Inc shares in Q2 2024, an estimated $1.
  • Macquarie Group first reported a position in LeonaBio Inc in Q3 2020 and held it in 2 quarters.
  • Macquarie Group's LeonaBio Inc position peaked at $92K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.